A 4-Week, Double-blind, Placebo-controlled, Randomized, Multicenter, Crossover Study of the Safety, Efficacy, and Pharmacokinetics of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate hydrochloride] in Subjects with Parkinson's Disease and Excessive Sleep
Research Grant
Administered By
Neurology, Movement Disorders
Awarded By
Jazz Pharmaceuticals
Start Date
May 15, 2017
End Date
September 12, 2019
Administered By
Neurology, Movement Disorders
Awarded By
Jazz Pharmaceuticals
Start Date
May 15, 2017
End Date
September 12, 2019